Quince Therapeutics, Inc.

8-K Director or officer change Jul 31, 2026 8-K/A Other events Jul 30, 2026 8-K/A Modified rights of security holders Jun 26, 2026 8-K Modified rights of security holders; Amended charter or bylaws Jun 26, 2026 8-K Shareholder vote results Jun 11, 2026 8-K Other events May 21, 2026 8-K/A Regulation FD disclosure May 18, 2026 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Director or officer change; Amended charter or bylaws; Regulation FD disclosure May 18, 2026 10-Q Quarter ended 2026-03-31 May 11, 2026 8-K Other events Apr 28, 2026 8-K Director or officer change Apr 22, 2026 10-K Fiscal year ended 2025-12-31 Apr 10, 2026 8-K Modified rights of security holders; Amended charter or bylaws Apr 9, 2026 8-K Terminated a material agreement; Regulation FD disclosure Mar 30, 2026 8-K Delisting notice or listing-rule failure Mar 20, 2026 8-K Results of operations (earnings release); Other events Feb 12, 2026 8-K Director or officer change Feb 2, 2026 8-K Other events Jan 29, 2026 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Regulation FD disclosure Oct 17, 2025 8-K Entered a material agreement; Took on a direct financial obligation Sep 26, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Results of operations (earnings release) Aug 11, 2025 8-K Regulation FD disclosure; Other events Jul 16, 2025 8-K Entered a material agreement; Unregistered sale of equity Jun 13, 2025 8-K Shareholder vote results Jun 5, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release) May 13, 2025 10-K Fiscal year ended 2024-12-31 Mar 24, 2025 8-K Results of operations (earnings release) Mar 24, 2025 8-K Other events Nov 14, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Results of operations (earnings release) Nov 13, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Results of operations (earnings release) Aug 13, 2024 8-K Delisting notice or listing-rule failure Jun 21, 2024 8-K Shareholder vote results Jun 6, 2024 10-Q Quarter ended 2024-03-31 May 13, 2024 10-K Fiscal year ended 2023-12-31 Apr 1, 2024